v3.26.1
Vendor Concentration
 12 Months Ended
Dec. 31, 2025
Risks and Uncertainties [Abstract]  
Vendor Concentration VENDOR CONCENTRATIONThe Company had five major vendors that accounted for approximately 27%, 20%, 17%, 16% and 10% of the Company's research and development expenses for the year ended December 31, 2025, and 3%, 2%, 0%, 2% and 6% of the Company's research and development expenditures for the year ended December 31, 2024. The same vendors accounted for 7% and 3% of the Company's total accounts payable and accrued expenses as of each of December 31, 2025 and 2024, respectively. The Company continues to maintain its relationship with these vendors and anticipates incurring significant expenses with these vendors over the next 12 months.